Incidence and etiological profile of second trimester abortion: a prospective observational study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20261464Keywords:
Second trimester abortion, Induced abortion, Spontaneous abortion, Cervical incompetence, Uterine anomalies, IncidenceAbstract
Background: Second trimester abortion, occurring between 14 and 24 weeks of gestation, is associated with higher maternal morbidity compared to first trimester termination. Despite its relatively lower incidence, it contributes disproportionately to abortion-related complications. Understanding the incidence and etiological factors is essential for improving preventive and clinical strategies. The aim was to determine the incidence and most common causes of second trimester abortion in a tertiary care center.
Methods: This prospective observational study was conducted in the Department of Obstetrics and Gynaecology at Government Raja Mirasudhar Hospital, Thanjavur Medical College, over a period of one year. A total of 315 women with second trimester abortion (14–24 weeks gestation) were included. Data regarding sociodemographic characteristics, obstetric profile, type of abortion (spontaneous or induced), and etiological factors were collected and analyzed. Descriptive statistics were used, and results were expressed as mean±standard deviation, frequencies, and percentages. Appropriate statistical tests were applied, with p<0.05 considered significant.
Results: The mean age of participants was 24.21±5.13 years. Induced abortions constituted 82.5% of cases, while spontaneous abortions accounted for 17.5%. The majority of abortions occurred between 17–19 weeks of gestation (45.7%). Among spontaneous abortions, unexplained causes were most common (52%), followed by cervical incompetence (13%) and uterine anomalies (11%). A statistically significant association was observed between age and type of abortion (p<0.05).
Conclusion: Second trimester abortion is predominantly induced, reflecting increasing reliance on medical termination for late-detected pregnancies and fetal anomalies. Among spontaneous abortions, a significant proportion remains unexplained, highlighting the need for improved diagnostic evaluation. Early identification of preventable causes such as cervical incompetence and enhanced antenatal care was essential to reduce maternal morbidity.
References
World Health Organization. Safe abortion: technical and policy guidance for health systems. 2012. Available at: https://iris.who.int/bitstream/handle/ 10665/70914/9789241548434_eng.pdf. Accessed on 10 February 2026.
Royal College of Obstetricians and Gynaecologists. The care of women requesting induced abortion. Evidence-based Clinical Guideline No. 7. London: RCOG. 2011. Available at: https://www.rcog.org.uk/ media/nwcjrf0o/abortion-guideline_web_1.pdf. Accessed on 10 February 2026.
Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, et al. Williams Obstetrics. 25th edition. New York: McGraw-Hill. 2018.
Sharma JB. Medical termination of pregnancy in India: trends and determinants. J Obstet Gynaecol India. 2015;65(6):369-74.
Rai R, Regan L. Antiphospholipid syndrome and pregnancy loss. N Engl J Med. 2006;355(23):2490-3.
Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med. 2000;342(20):1500-7.
Ananth CV, Smulian JC, Vintzileos AM. Incidence and risk factors for placental abruption. Obstet Gynecol. 1999;93(4):622-6.
Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss. Fertil Steril. 2012;98(5):1103-11.
Bartley J, Baird DT. A randomized study of mifepristone in combination with misoprostol for second trimester abortion. Br J Obstet Gynaecol. 2002;109(11):1290-4.
Government of India. The Medical Termination of Pregnancy Act, 1971 and Amendment Act, 2021. New Delhi: Ministry of Health and Family Welfare. 2021. Available at: https://prsindia.org/files/bills_ acts/acts_parliament/2021/Medical%20Termination%20of%20Pregnancy%20Amendment%20Act%202021.pdf. Accessed on 10 February 2026.
World Health Organization. Abortion care guideline. 2022. Available at: https://www.who.int/publica tions/i/item/9789240039483. Accessed on 10 February 2026.
American College of Obstetricians and Gynecologists. Practice Bulletin No. 135: Second-trimester abortion. Obstet Gynecol. 2013;121(6):1394-406.
Patel U, Goyal V, Jain R. Second trimester abortion: a review of current practices. J Obstet Gynaecol India. 2013;63(6):393-9.
Kapp N, Whyte P, Tang J, Jackson E, Brahmi D. A review of evidence for safe abortion care. Contraception. 2013;88(3):350-63.
Lichtenberg ES. Complications of second trimester abortion. Clin Obstet Gynecol. 2014;57(1):130-40.
Forastiero RR, Martinuzzo ME, Carreras LO. Anti-beta2 glycoprotein I antibodies and thrombotic risk in antiphospholipid syndrome. Thromb Res. 2005;115(3):189-94.
Bebbington MW, Kent N, Lim K, Gagnon A, Delisle MF. A randomized controlled trial comparing oral and vaginal misoprostol for mid-trimester termination. Am J Obstet Gynecol. 2002;186(5):1038-42.
Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: pharmacokinetic profiles and routes of administration. Hum Reprod Update. 2007;13(5):473-82.
Mukherjee AA, Bawa AK, Singh S. Comparative study of sublingual versus vaginal misoprostol for second trimester abortion. Int J Reprod Contracept Obstet Gynecol. 2019;8(3):1023-8.
Nautiyal D, Singh S, Rani R. Comparative study of different routes of misoprostol in first and second trimester abortion. J Obstet Gynaecol India. 2015;65(5):327-31.
Balasubramanian I, Suresh N. Comparative study of mifepristone with misoprostol versus misoprostol alone in second trimester abortion. J Clin Diagn Res. 2013;7(9):1983-6.
Dickinson JE, Brownell P, McGinnis K, Nathan EA. A comparison of medical abortion with mifepristone and misoprostol versus misoprostol alone for second trimester termination. BJOG. 2010;117(6):708-15.
Downloads
Published
How to Cite
Issue
Section
